Interferon Regulatory Factor 6 Determines Intestinal Epithelial Cell Development and Immunity.


Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
09 Apr 2024
Historique:
received: 12 01 2024
revised: 21 03 2024
accepted: 31 03 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 11 4 2024
Statut: aheadofprint

Résumé

Intestinal epithelial cell (IEC) responses to interferon (IFN) favor antiviral defense with minimal cytotoxicity, but IEC-specific factors that regulate these responses remain poorly understood. Interferon regulatory factors (IRFs) are a family of nine related transcription factors, and IRF6 is preferentially expressed by epithelial cells, but its roles in IEC immunity are unknown. In this study, CRISPR screens found that Irf6 deficiency enhanced IFN-stimulated antiviral responses in transformed mouse IECs but not macrophages. Furthermore, KO ofIrf6in IEC organoids resulted in profound changes to homeostasis and immunity gene expression. Irf6 KO organoids grew more slowly, and single-cell RNA sequencing indicated reduced expression of genes in epithelial differentiation and immunity pathways. IFN-stimulated gene expression was also significantly different inIrf6KO organoids, with increased expression of stress and apoptosis-associated genes. Functionally, the transcriptional changes in Irf6 KO organoids were associated with increased cytotoxicity upon IFN treatment or inflammasome activation. These data indicate a previously unappreciated role for IRF6 in IEC biology, including regulation of epithelial development and moderation of innate immune responses to minimize cytotoxicity and maintain barrier function.

Identifiants

pubmed: 38604478
pii: S1933-0219(24)00032-1
doi: 10.1016/j.mucimm.2024.03.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Austin P Wright (AP)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Sydney Harris (S)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Shelby Madden (S)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Bryan Ramirez Reyes (B)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Ethan Mulamula (E)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Alexis Gibson (A)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Isabella Rauch (I)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

David A Constant (DA)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.

Timothy J Nice (TJ)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: nice@ohsu.edu.

Classifications MeSH